• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov15
Fortress Biotech released FY2025 9 Months Earnings on November 14 After-Market EST, actual revenue USD 47.18 M, actual EPS USD 0.0792
00:00
Fortress Biotech released FY2025 Q3 earnings on November 14 After-Market EST, actual revenue USD 17.63 M (forecast USD 21.02 M), actual EPS USD 0.11 (forecast USD -0.625)
00:00
Nov14
Fortress Biotech Reports Significant Improvements in Q3 2025 10-Q
13:57
Nov5
Fortress Biotech to Release FY2025 Q3 Earnings on November 12 After-Market EST, Forecast Revenue USD 21.02 M, EPS USD -0.625
00:07
Oct21
Fortress Biotech Subsidiary Urica Therapeutics Announces Initiation of Phase 3 Clinical Trials for dotinurad
12:31
Aug14
Fortress Biotech released FY2025 Semi-Annual Earnings on August 14 After-Market (EST), Actual Revenue USD 29.55 M, Actual EPS USD 0.02
23:00

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 17.63 M, Net Income 3.675 M, EPS 0.11

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 16.41 M, Net Income 13.36 M, EPS 0.45

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 13.14 M, Net Income -12.72 M, EPS -0.4807

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
20.080
+197.13%
+13.903
SMX
301.230
+113.64%
+160.230
WHLR
5.768
+78.01%
+2.489
GURE
8.051
+69.85%
+3.311
DBRG
14.265
+46.76%
+4.560
IRBT
4.300
+41.92%
+1.280
TORO
5.490
+32.93%
+1.360
TDIC
0.3655
+30.16%
+0.085
SPHL
4.331
+30.05%
+1.001
PRAX
246.420
+29.72%
+56.450
View More